• FirefoxInstall the new Firefox »
  •  Dow Down 0.54% Nasdaq Down 0.44%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    5.60 Down 0.38(6.35%) 2:29PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.98
    Open:5.92
    Bid:5.60 x 100
    Ask:5.63 x 200
    1y Target Est:21.00
    Beta:1.935
    Earnings Date:Apr 8 - Apr 15 (Est.)
    Day's Range:5.50 - 6.09
    52wk Range:3.12 - 22.19
    Volume:197,301
    Avg Vol (3m):347,395
    Market Cap:76.73M
    P/E (ttm):N/A
    EPS (ttm):-2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADHD

    Comparison

    Symbol% ChgMkt Cap
    ADHDDown 6.35%76.73M
    JNJDown 0.70%280.38B
    NVSDown 2.32%237.37B
    SHPGDown 0.64%47.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.28
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback